» Articles » PMID: 29618986

The Antioxidant Therapy: New Insights in the Treatment of Hypertension

Overview
Journal Front Physiol
Date 2018 Apr 6
PMID 29618986
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) play a key role in the regulation of the physiological and pathological signaling within the vasculature. In physiological conditions, a delicate balance between oxidants and antioxidants protects cells from the detrimental effects of ROS/RNS. Indeed, the imbalance between ROS/RNS production and antioxidant defense mechanisms leads to oxidative and nitrosative stress within the cell. These processes promote the vascular damage observed in chronic conditions, such as hypertension. The strong implication of ROS/RNS in the etiology of hypertension suggest that antioxidants could be effective in the treatment of this pathology. Indeed, in animal models of hypertension, the overexpression of antioxidants and the genetic modulation of oxidant systems have provided an encouraging proof of concept. Nevertheless, the translation of these strategies to human disease did not reach the expected success. This could be due to the complexity of this condition, whose etiology depends on multiple factors (smoking, diet, life styles, genetics, family history, comorbidities). Indeed, 95% of reported high blood pressure cases are deemed "essential hypertension," and at the molecular level, oxidative stress seems to be a common feature of hypertensive states. In this scenario, new therapies are emerging that could be useful to reduce oxidative stress in hypertension. It is now ascertained the role of Vitamin D deficiency in the development of essential hypertension and it has been shown that an appropriate high dose of Vitamin D significantly reduces blood pressure in hypertensive cohorts with vitamin D deficiency. Moreover, new drugs are emerging which have both antihypertensive action and antioxidant properties, such as celiprolol, carvedilol, nebivolol. Indeed, besides adrenergic desensitization, these kind of drugs are able to interfere with ROS/RNS generation and/or signaling, and are therefore considered promising therapeutics in the management of hypertension. In the present review we have dealt with the effectiveness of the antioxidant therapy in the management of hypertension. In particular, we discuss about Vitamin D and anti-hypertensive drugs with antioxidant properties.

Citing Articles

Supplementation with Standardized Green/Black or White Tea Extracts Attenuates Hypertension and Ischemia-Reperfusion-Induced Myocardial Damage in Mice Infused with Angiotensin II.

de la Fuente-Munoz M, Roman-Carmena M, Amor S, Iglesias-de la Cruz M, Martorell P, Guilera-Bermell S Antioxidants (Basel). 2025; 14(1).

PMID: 39857381 PMC: 11762166. DOI: 10.3390/antiox14010047.


Correlation of physicochemical properties with antioxidant activity in phenol and thiophenol analogues.

Vlocsko R, Mastyugin M, Torok B, Torok M Sci Rep. 2025; 15(1):73.

PMID: 39747219 PMC: 11697322. DOI: 10.1038/s41598-024-83982-4.


Dietary antioxidant index and hypertension in the Iranian population: a nested case-control study within the Fasa adults cohort study.

Firooznia M, Rahimlou M, Sekhavati E, Motazedian M, Tabrizi R Front Nutr. 2024; 11:1476122.

PMID: 39713776 PMC: 11659007. DOI: 10.3389/fnut.2024.1476122.


Solvent- and Catalyst-Free Environmentally Benign High Hydrostatic Pressure-Assisted Synthesis of Bioactive Hydrazones and the Evaluation of Their Stability Under Various Storage Conditions.

Costa M, Adhamidhi F, Mastyugin M, Fusco A, Lazarev A, Zsengeller Z Molecules. 2024; 29(22).

PMID: 39598676 PMC: 11596250. DOI: 10.3390/molecules29225287.


Total sputum nitrate/nitrite is associated with exacerbations and colonisation in bronchiectasis.

Zhou Y, He X, Tang J, Zhang D, Liu Y, Xue Y ERJ Open Res. 2024; 10(4).

PMID: 39040581 PMC: 11261385. DOI: 10.1183/23120541.01045-2023.


References
1.
Egea J, Fabregat I, Frapart Y, Ghezzi P, Gorlach A, Kietzmann T . European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol. 2017; 13:94-162. PMC: 5458069. DOI: 10.1016/j.redox.2017.05.007. View

2.
Touyz R, Schiffrin E . Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens. 2001; 19(7):1245-54. DOI: 10.1097/00004872-200107000-00009. View

3.
Kukin M, Kalman J, Charney R, Levy D, Ocampo O, Eng C . Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation. 1999; 99(20):2645-51. DOI: 10.1161/01.cir.99.20.2645. View

4.
Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm B . Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta. 2010; 411(17-18):1354-60. DOI: 10.1016/j.cca.2010.05.037. View

5.
Ruef J, Hu Z, Yin L, Wu Y, Hanson S, Kelly A . Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res. 1997; 81(1):24-33. DOI: 10.1161/01.res.81.1.24. View